Jim Powers is the founder of HemoShear Therapeutics. HemoShear Therapeutics has raised $53M in total funding. Latest round: Series A.
Jim Powers serves as chairman and CEO of HemoShear Therapeutics, a clinical-stage biotechnology company developing treatments for rare metabolic disorders. He leads the company's efforts to advance its rare disease portfolio, including a Phase 2 study of lead compound HST5040 for methylmalonic acidemia and propionic acidemia.
Full founder directory · Investor directory · Company funding database · Fundraising library